Nu Skin Enterprises, Inc. (NYSE:NUS) Receives Average Recommendation of “Hold” from Brokerages
Nu Skin Enterprises, Inc. (NYSE:NUS) has been given a consensus recommendation of “Hold” by the ten brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $62.25.
Several analysts have recently commented on the company. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research note on Wednesday, July 12th. Bank of America Corporation raised their price target on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research report on Monday, July 10th. Deutsche Bank AG raised their price target on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Pivotal Research reissued a “buy” rating and set a $65.00 target price on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Finally, ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd.
Shares of Nu Skin Enterprises (NUS) traded up 1.42% during midday trading on Tuesday, hitting $65.62. The company had a trading volume of 553,668 shares. Nu Skin Enterprises has a one year low of $46.35 and a one year high of $66.04. The stock’s 50-day moving average price is $61.39 and its 200-day moving average price is $55.35. The stock has a market capitalization of $3.47 billion, a price-to-earnings ratio of 21.78 and a beta of 1.31.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.01. Nu Skin Enterprises had a return on equity of 23.45% and a net margin of 7.48%. The business had revenue of $499.10 million during the quarter, compared to the consensus estimate of $493.65 million. During the same period in the prior year, the business posted $0.42 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 5.8% on a year-over-year basis. Analysts predict that Nu Skin Enterprises will post $3.12 EPS for the current year.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the company’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $58.32, for a total value of $466,560.00. Following the sale, the general counsel now owns 53,730 shares in the company, valued at $3,133,533.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders have sold 24,250 shares of company stock worth $1,436,770 in the last quarter. 5.20% of the stock is owned by corporate insiders.
A number of large investors have recently made changes to their positions in NUS. Independent Portfolio Consultants Inc. boosted its stake in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares during the last quarter. ProShare Advisors LLC bought a new position in shares of Nu Skin Enterprises during the first quarter worth $245,000. Profund Advisors LLC bought a new position in shares of Nu Skin Enterprises during the first quarter worth $384,000. Nationwide Fund Advisors increased its position in shares of Nu Skin Enterprises by 4.3% in the first quarter. Nationwide Fund Advisors now owns 84,011 shares of the company’s stock worth $4,666,000 after buying an additional 3,444 shares during the period. Finally, Retirement Systems of Alabama bought a new position in shares of Nu Skin Enterprises during the first quarter worth $3,543,000. Institutional investors and hedge funds own 85.58% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.